Novo Nordisk Shares Plunge 21% Toward Worst Day In 40 Years—As Ozempic Sales Expected To Slow
- Posted on July 29, 2025
- By Forbes
- 4 Views
Novo Nordisk Shares Plunge 21% Toward Worst Day In 40 Years—As Ozempic Sales Expected To Slow
The Danish firm said weaker Wegovy and Ozempic sales are expected as competition ramps up and compounded options become more available.
